Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | GSK | ARGX | ||
| Company | Alexion Pharm Inc | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 181.04 | 33.40 | 587.39 | ||
| High | 182.67 | 33.70 | 601.95 | ||
| Low | 180.13 | 33.18 | 582.07 | ||
| Last | 182.50 | 33.70 | 596.74 | ||
| Change | +3.05 | +0.35 | +4.92 | ||
| % Change | +1.70% | +1.05% | +0.83% | ||
| Volume | 90,506,096 | 7,030,600 | 417,700 | ||
| 20-Day Average Volume | 8,395,359 | 8,395,450 | 325,220 | ||
| Previous Close | 179.45 | 33.35 | 591.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 35.80 | 581.89 | ||
| 20-Day Raw Stochastic | 44.63% | 16.11% | 77.95% | ||
| 20-Day Relative Strength | 55.14% | 30.55% | 59.09% | ||
| Weighted Alpha | +62.81 | -15.44 | +38.82 | ||
| Today's Opinion | 72% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 100% Sell | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | -2.01% since 11/14/24 | +0.29% since 11/14/24 | ||
| Low | 178.51 on 07/19/21 | 32.83 on 11/15/24 | 558.15 on 11/19/24 | ||
| High | 187.45 on 07/14/21 | 33.79 on 11/18/24 | 601.95 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | -11.69% since 10/21/24 | +6.48% since 10/21/24 | ||
| Low | 178.51 on 07/19/21 | 32.83 on 11/15/24 | 545.55 on 10/30/24 | ||
| High | 187.45 on 07/14/21 | 38.26 on 10/29/24 | 611.22 on 11/05/24 | ||
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | -19.47% since 08/21/24 | +13.56% since 08/21/24 | ||
| Low | 164.83 on 04/29/21 | 32.83 on 11/15/24 | 511.19 on 08/27/24 | ||
| High | 187.45 on 07/14/21 | 44.67 on 08/27/24 | 611.22 on 11/05/24 | ||
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | -24.20% since 05/21/24 | +67.31% since 05/21/24 | ||
| Low | 146.97 on 03/04/21 | 32.83 on 11/15/24 | 358.80 on 05/24/24 | ||
| High | 187.45 on 07/14/21 | 45.79 on 05/22/24 | 611.22 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 69,119,536 | 35,388,472 | ||
| Shares Outstanding, K | 221,019 | 2,072,550 | 59,796 | ||
| Annual Sales | 6,069,900,000 | 37,725,000,000 | 1,268,590,000 | ||
| Annual Net Income | 603,400,000 | 6,129,940,000 | -295,050,000 | ||
| Last Quarter Sales | 1,636,500,000 | 10,420,410,000 | 588,880,000 | ||
| Last Quarter Net Income | 636,000,000 | -75,430,000 | 91,410,000 | ||
| 60-Month Beta | 1.25 | 0.66 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 1.27 on 10/30/24 | 1.39 on 10/31/24 | ||
| Latest Earnings Date | 07/29/21 | 10/30/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | 0.382 on 11/15/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/15/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 8.02 | 0.00 | ||